Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)
Conditions:   Rhinitis, Allergic, Seasonal;   Rhinitis, Allergic, PerennialInterventions:   Drug: 5-mg Desloratadine;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2006 Category: Research Source Type: clinical trials